BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17083567)

  • 21. Cathepsin B is a target of Hedgehog signaling in pancreatic cancer.
    Hwang JH; Lee SH; Lee KH; Lee KY; Kim H; Ryu JK; Yoon YB; Kim YT
    Cancer Lett; 2009 Jan; 273(2):266-72. PubMed ID: 19004543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation.
    Liao X; Siu MK; Au CW; Wong ES; Chan HY; Ip PP; Ngan HY; Cheung AN
    Carcinogenesis; 2009 Jan; 30(1):131-40. PubMed ID: 19028702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
    Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
    Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.
    Singh RR; Kim JE; Davuluri Y; Drakos E; Cho-Vega JH; Amin HM; Vega F
    Leukemia; 2010 May; 24(5):1025-36. PubMed ID: 20200556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
    Yu X; Liu L; Cai B; He Y; Wan X
    Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
    Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
    Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
    Levitt RJ; Zhao Y; Blouin MJ; Pollak M
    Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation.
    Wang L; Cao XX; Chen Q; Zhu TF; Zhu HG; Zheng L
    Cancer Sci; 2009 Oct; 100(10):1801-8. PubMed ID: 19572978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LKB1 suppresses proliferation and invasion of prostate cancer through hedgehog signaling pathway.
    Xu P; Cai F; Liu X; Guo L
    Int J Clin Exp Pathol; 2014; 7(12):8480-8. PubMed ID: 25674212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
    Chan DW; Liu VW; Tsao GS; Yao KM; Furukawa T; Chan KK; Ngan HY
    Carcinogenesis; 2008 Sep; 29(9):1742-50. PubMed ID: 18632752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice.
    Sanchez P; Ruiz i Altaba A
    Mech Dev; 2005 Feb; 122(2):223-30. PubMed ID: 15652709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells.
    Kobune M; Takimoto R; Murase K; Iyama S; Sato T; Kikuchi S; Kawano Y; Miyanishi K; Sato Y; Niitsu Y; Kato J
    Cancer Sci; 2009 May; 100(5):948-55. PubMed ID: 19245435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of sonic hedgehog signaling in oral squamous cell carcinomas: a preliminary study.
    Cavicchioli Buim ME; Gurgel CA; Gonçalves Ramos EA; Lourenço SV; Soares FA
    Hum Pathol; 2011 Oct; 42(10):1484-90. PubMed ID: 21496866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent requirement of hedgehog signaling in non-small cell lung carcinoma.
    Yuan Z; Goetz JA; Singh S; Ogden SK; Petty WJ; Black CC; Memoli VA; Dmitrovsky E; Robbins DJ
    Oncogene; 2007 Feb; 26(7):1046-55. PubMed ID: 16909105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosstalk of hedgehog and Wnt pathways in gastric cancer.
    Yanai K; Nakamura M; Akiyoshi T; Nagai S; Wada J; Koga K; Noshiro H; Nagai E; Tsuneyoshi M; Tanaka M; Katano M
    Cancer Lett; 2008 May; 263(1):145-56. PubMed ID: 18243529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activin is a potent growth suppressor of epithelial ovarian cancer cells.
    Ramachandran A; Marshall ES; Love DR; Baguley BC; Shelling AN
    Cancer Lett; 2009 Nov; 285(2):157-65. PubMed ID: 19493612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sonic and desert hedgehog signaling in human fetal prostate development.
    Zhu G; Zhau HE; He H; Zhang L; Shehata B; Wang X; Cerwinka WH; Elmore J; He D
    Prostate; 2007 May; 67(6):674-84. PubMed ID: 17342747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-canonical Hedgehog signaling activation in ovarian borderline tumors and ovarian carcinomas.
    Ozretić P; Trnski D; Musani V; Maurac I; Kalafatić D; Orešković S; Levanat S; Sabol M
    Int J Oncol; 2017 Dec; 51(6):1869-1877. PubMed ID: 29039491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation.
    Chaudary N; Pintilie M; Hedley D; Fyles AW; Milosevic M; Clarke B; Hill RP; Mackay H
    Cancer; 2012 Jun; 118(12):3105-15. PubMed ID: 22028038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.